High rates of obesity among middle-aged Black women with HIV in UK cohort


Around 40% of the women living with HIV in the UK aged 45-60 had a body mass index (BMI) greater than or equal to 30, considered obese, according to a study recently published in HIV Medicine. After controlling for other factors, researchers found that Black women were more likely to be obese than White British women.  

Worldwide, obesity has tripled in prevalence since the 1970s, and in 2016, about 13% of the world’s population was obese. Obesity peaks in middle age for both men and women. Obesity more often impacts people with HIV, and a recent study found that 25% of people living with HIV aged 50 or older in the UK were obese. Weight gain contributes to heart, liver, and kidney disease in people with HIV.

Obesity in people living with HIV doesn’t have a single cause; rather it has a relationship with certain antiretroviral medications, immune restoration, behavioural factors, and social inequalities. Women with HIV are more likely to gain weight after starting antiretroviral therapy than men.


body mass index (BMI)

Body mass index, or BMI, is a measure of body size. It combines a person's weight with their height. The BMI gives an idea of whether a person has the correct weight for their height. Below 18.5 is considered underweight; between 18.5 and 25 is normal; between 25 and 30 is overweight; and over 30 is obese. Many BMI calculators can be found on the internet.


A group of diseases characterized by high levels of blood sugar (glucose). Type 1 diabetes occurs when the body fails to produce insulin, which is a hormone that regulates blood sugar. Type 2 diabetes occurs when the body either does not produce enough insulin or does not use insulin normally (insulin resistance). Common symptoms of diabetes include frequent urination, unusual thirst and extreme hunger. Some antiretroviral drugs may increase the risk of type 2 diabetes.

trial design

How a clinical study or trial is structured to answer the questions being asked, e.g., open-label or double-blind, comparative or observational.


The presence of one or more additional health conditions at the same time as a primary condition (such as HIV).


A precursor to a building block of DNA or RNA. Nucleosides must be chemically changed into nucleotides before they can be used to make DNA or RNA. 

Menopause can also contribute to weight gain and redistribution of body fat. The number of people with HIV experiencing menopause in the UK has tripled in the last decade; however, little is known about the relationship between menopause and obesity among people living with HIV.

In the medical field, obesity is usually measured by body mass index (BMI), which uses height and weight to measure a person’s body mass and then categorises them as underweight, normal, overweight, or obese.

Critics of BMI note that BMI gives no insight into where fat is stored in the body, which is significant to health risks. The UK’s National Institute for Health and Care Excellence (NICE) recently updated their guidelines to recommend that even adults with “normal” BMIs should keep their waist measurement to half their height. Waist measurements can help identify central adiposity – or storing fat in the midsection – which is a risk factor for diabetes, high blood pressure, and heart disease.

Asma Ashraf of University College London and colleagues set out to measure how common obesity was in middle-aged women living with HIV in the UK and whether menopause or other factors were related to obesity. Of note, obesity in the study was measured by body mass index (BMI).

This analysis is part of the larger Positive Transitions Through the Menopause (PRIME) Study, a cross sectional, mixed methods observation study that looks at menopause in women living with HIV aged 45-60 years.

The PRIME study recruited women from National Health Service HIV clinics between 2016 and 2017. Participants completed questionnaires about demographic, health and social factors, while information on weight and height were taken from medical records. Eligible participants were those who assigned female at birth who had not had surgical menopause and those who had not gone five or more years without a menstrual cycle (period).  

A total of 396 women with an average age of 49 were included in the study. The sample was largely reflective of women living with HIV in the UK. Most participants were of Black African ethnicity (72%), followed by White British (14%), other Black ethnicities, including mixed race and Caribbean (7%) and the rest had an ethnicity described as other (7%). Most (84%) participants were not born in the UK but did have secure immigration status (95%).

Nearly half of participants had finished school (47%) and a little over half (52%) were employed full-time, while a third had no employment. Thirty-eight per cent reported not having enough money for basic needs some or all of the time. As reported earlier, psychological distress and mental health problems were common among this cohort yet inadequately treated; this may be attributed to structural racism.

All participants were prescribed ART and 89% were undetectable. Most (72%) had CD4 cell counts above 500 and 4% had counts below 200. Most women were on a non-nucleoside reverse transcriptase inhibitor regimen (48%), followed by a protease inhibitor regimen (29%). Only 13% of participants were on an integrate inhibitor regimen, which is the ART class notorious for weight gain.

Menopause status was determined from self-report and was not confirmed biologically. Twenty-one per cent of participants were pre-menopausal (regular menstruation), 48% were peri-menopausal (irregular periods over the previous two years) and 31% were post-menopausal (no period for 12 months or more).

"The study did not find a link between socioeconomic factors and obesity, but the lack of detailed socioeconomic data is a limitation of the study."

The median BMI was 29, and 28% of participants had a normal weight (BMI below 25), 32% were overweight (BMI between 25 and 29.9), and 40% were obese (BMI over 30). Four participants had BMIs less than 18.5 and were considered underweight. Median BMI differed by race and ethnicity, with it being 29 for Black African participants, 31 for other Black participants, 24 for White British participants, and 25 for other ethnicities. These differences were statistically significant.

Researchers performed univariable analysis and found that being Black, being born outside of the UK, and having a greater number of medical conditions were associated with having a higher BMI, while current smoking was associated with having a lower BMI.

However, after adjusting for other factors, ethnicity was the only factor that remained significant. Compared to White British participants, Black African women were 2.5 times more likely to be obese (95% confidence interval: 0.94-6.7) and those of other Black ethnicities were seven times more likely to be obese (95% CI: 2.15-23.72).

The association between obesity and race/ethnicity is not unexpected. Overall in the UK 68% of Black adults are overweight or obese, higher than in other groups. Some possible contributing factors the authors mentioned include migration to an environment that is more likely to cause obesity; cultural factors including diet, lifestyle, and physical activity; and socioeconomic status.

This study did not find a link between socioeconomic factors and obesity; however, Ashraf and colleagues cited the lack of detailed data on these factors as a limitation of the study. The researchers didn’t consider factors such as food insecurity, diet and exercise. The study design, which did not allow the researchers to look at weight gain over time or to determine the direction between some associations, was another limitation of the study.

These findings underscore the importance of monitoring and recording BMI among middle-aged women in practice, since it’s likely that HIV and obesity have synergistic effects on co-morbidities, which can also be more likely post-menopause. The authors call for developing interventions that are culturally appropriate and acceptable to ethnically diverse women living with HIV for middle age and beyond, noting that their needs differ from men living with HIV.


Ashraf A et al. Obesity in women living with HIV aged 45–60 in England: an analysis of the PRIME study. HIV Medicine, 23: 371-377, April 2022 (open access).

doi: 10.1111/hiv.13242